Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period
This article was originally published in The Gray Sheet
Executive Summary
Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee
You may also be interested in...
MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed
Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains
MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed
Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains
Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists
CMS' reliance on the precise wording of Guidant's original national coverage determination request for expanded ICD use suggests the need for companies to tailor their requests to avoid overly broad interpretations